Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneityBiswanath Majumder(National Centre for Biological Sciences), Pradip K. Majumder(Wave Life Sciences (United States))Nature CommunicationsFebruary 27, 201510.1038/ncomms7169Cited by 307SaveCiteExport RISWatch citationsRelated PapersmTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways|Nature Medicine|2004|956